1. Home
  2. MNKD vs YY Comparison

MNKD vs YY Comparison

Compare MNKD & YY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • YY
  • Stock Information
  • Founded
  • MNKD 1991
  • YY 2005
  • Country
  • MNKD United States
  • YY Singapore
  • Employees
  • MNKD N/A
  • YY N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • YY EDP Services
  • Sector
  • MNKD Health Care
  • YY Technology
  • Exchange
  • MNKD Nasdaq
  • YY Nasdaq
  • Market Cap
  • MNKD 1.8B
  • YY 1.9B
  • IPO Year
  • MNKD 2004
  • YY 2012
  • Fundamental
  • Price
  • MNKD $6.80
  • YY $36.66
  • Analyst Decision
  • MNKD Strong Buy
  • YY Hold
  • Analyst Count
  • MNKD 5
  • YY 3
  • Target Price
  • MNKD $8.40
  • YY $35.00
  • AVG Volume (30 Days)
  • MNKD 2.9M
  • YY 376.6K
  • Earning Date
  • MNKD 11-07-2024
  • YY 11-26-2024
  • Dividend Yield
  • MNKD N/A
  • YY 4.72%
  • EPS Growth
  • MNKD N/A
  • YY 5.68
  • EPS
  • MNKD 0.08
  • YY 4.01
  • Revenue
  • MNKD $267,200,000.00
  • YY $2,266,596,000.00
  • Revenue This Year
  • MNKD $46.83
  • YY $1.86
  • Revenue Next Year
  • MNKD $14.40
  • YY $3.38
  • P/E Ratio
  • MNKD $85.77
  • YY $9.14
  • Revenue Growth
  • MNKD 51.35
  • YY N/A
  • 52 Week Low
  • MNKD $3.17
  • YY $27.88
  • 52 Week High
  • MNKD $7.63
  • YY $42.65
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 47.15
  • YY 63.94
  • Support Level
  • MNKD $6.61
  • YY $33.00
  • Resistance Level
  • MNKD $7.44
  • YY $34.88
  • Average True Range (ATR)
  • MNKD 0.35
  • YY 1.01
  • MACD
  • MNKD -0.05
  • YY 0.36
  • Stochastic Oscillator
  • MNKD 18.63
  • YY 89.27

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About YY JOYY Inc.

JOYY Inc is a global technology company offering comprehensive innovation capabilities. The company enables users to interact with others in real time. The group is actively exploring and expanding its global commerce Software-as-a-Service and solutions business. JOYY emphasizes technological innovation and is recognized in the industry for its significant number of patent applications and licenses.

Share on Social Networks: